Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00306917 · ClinicalTrials.gov registry record · NA
Clinical Study Comparing Two Implant Surface Finishes in Patients Undergoing Cementless Total Hip Replacement
A NA study, sponsored by DePuy Orthopaedics.
- Terminated
- Registry status
- NA
- Development phase
- 245
- Enrollment target
NCT00306917: Clinical Trial NA study, sponsored by DePuy Orthopaedics.
NCT00306917 is a NA study that was terminated before completion, run by DePuy Orthopaedics. The registered enrollment target is 245 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00306917, a NA study, was terminated before completion, sponsored by DePuy Orthopaedics.
- TERMINATED
- Registry status
- NA
- Development phase
- 245 participants
- Enrollment target
Study Summary
Prospective, randomized study of Summit Porocoat versus Summit DuoFix HA in total hip arthroplasty
Primary Outcome
The Harris Hip scoring system assigns a numeric value to responses from patients and assessments made by a surgeon. A score of 90-100 is excellent, 80-90 is good, 70-80 is fair, 60-69 is poor, and 60 or below is failed. The patient records the following: pain level, need for assistance when walking, presence of a limp, distance able to walk, ability to put on shoes and socks, climb stairs, use public transportation and the length of time one is able to comforatably sit in a chair are all scored.
Interventions
- DEVICE non-coated femoral hip stem
- DEVICE coated femoral hip stem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 245 participants |
| Start Date | 2002-11-01 |
| Est. Completion | 2009-01-29 |
| Phase | NA |
Why NCT00306917 stopped before completion
NCT00306917 is an interventional study that assigns participants to a tested intervention. The registered 245 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 2 interventions - of which non-coated femoral hip stem is the first listed.
NCT00306917 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00306917 about?
NCT00306917 is a clinical study titled "Clinical Study Comparing Two Implant Surface Finishes in Patients Undergoing Cementless Total Hip Replacement". Prospective, randomized study of Summit Porocoat versus Summit DuoFix HA in total hip arthroplasty
What is the current status of trial NCT00306917?
This trial is currently terminated. It is a NA study. The enrollment target is 245 participants. The study started on 2002-11-01. Estimated completion is 2009-01-29.
What interventions are being tested in trial NCT00306917?
The interventions under investigation include: non-coated femoral hip stem (DEVICE), coated femoral hip stem (DEVICE).
Who is sponsoring clinical trial NCT00306917?
This trial is sponsored by DePuy Orthopaedics, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00306917's enrollment target sits among peer trials
245 436th of 2000 higher than 1,563 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03645928 · 245 participants · Phase 2
Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors
- NCT04718168 · 245 participants · NA
GORE® ENFORM Biomaterial Product Study
- NCT05145127 · 245 participants · Phase 3
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
- NCT05446259 · 245 participants
Degenerative Cervical Myelopathy Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI